Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:ELGX

Endologix (ELGX) Stock Price, News & Analysis

Endologix logo

About Endologix Stock (NASDAQ:ELGX)

Key Stats

Today's Range
$0.07
$0.08
50-Day Range
$0.02
$0.22
52-Week Range
$0.22
$7.10
Volume
85,372 shs
Average Volume
1.28 million shs
Market Capitalization
$1.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.

Receive ELGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Endologix and its competitors with MarketBeat's FREE daily newsletter.

ELGX Stock News Headlines

This is the worst sign for the U.S. stock market in 50 years
The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"
See More Headlines

ELGX Stock Analysis - Frequently Asked Questions

Endologix, Inc. (NASDAQ:ELGX) posted its earnings results on Monday, May, 11th. The medical instruments supplier reported ($0.80) EPS for the quarter, missing the consensus estimate of ($0.67) by $0.13. The medical instruments supplier earned $28.51 million during the quarter, compared to analysts' expectations of $28.50 million. Endologix had a negative trailing twelve-month return on equity of 63.96% and a negative net margin of 44.65%.

Endologix shares reverse split before market open on Wednesday, March 6th 2019. The 1-10 reverse split was announced on Tuesday, March 5th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, March 5th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Endologix investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH) and Gran Tierra Energy (GTE).

Company Calendar

Last Earnings
5/11/2020
Today
12/22/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:ELGX
CUSIP
29266S10
Fax
N/A
Employees
528
Year Founded
N/A

Profitability

Net Income
$-64,760,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$143.37 million
Book Value
$3.56 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.41 million
Optionable
Optionable
Beta
0.73
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:ELGX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners